Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year 0 21.06.2024 23:29 CNBC Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution" in the two trials. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
